Haemonetics | HAE - 営業利益

株価
59.93
毎日の変更
0.31 0.52%
毎月
7.15%
毎年
-4.13%
Q2 予測
58.65




営業利益 変化する 日付
Avanos Medical USD 24.77M 5.8M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Boston Scientific USD 1.24B 203M 2025-12
Cerus USD -1.45M 488K 2024-12
Cooper Companies USD 212.8M 72.4M 2025-12
Fresenius EUR 713M 139M 2025-12
Fresenius Medical Care EUR 663M 213.06M 2025-12
Globus Medical USD 181.31M 298.83M 2025-12
Haemonetics USD 67.4M 8.9M 2025-12
ICU Medical USD 26.09M 770K 2025-12
Intuitive Surgical USD 859.7M 5.6M 2026-03
Masimo USD 83.9M 300K 2025-12
Medtronic USD 1.74B 40M 2025-12
Merit Medical Systems USD 54.2M 11.58M 2025-12
Neogen USD -3.3M 2.08M 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Plus Therapeutics USD -5.74M 1.26M 2025-12
Quidel USD -37.3M 667.5M 2025-12
ResMed USD 497.6M 35.25M 2025-12
STAAR Surgical USD -10.93M 29.42M 2025-12
Steris USD 278M 7.1M 2025-12
Stryker USD 1.97B 609M 2025-12
Surmodics USD 58K 5.7M 2025-06
Teleflex USD 36.34M 445.24M 2025-12
Terumo JPY 43.88B 1.21B 2025-12
Thermo Fisher Scientific USD 1.91B 389M 2026-03
US Physical Therapy USD 16.77M 8.52M 2025-12
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12